Related Experiment Video

Updated: Mar 24, 2026

Making MR Imaging Child's Play - Pediatric Neuroimaging Protocol, Guidelines and Procedure
15:18

Making MR Imaging Child's Play - Pediatric Neuroimaging Protocol, Guidelines and Procedure

Published on: July 30, 2009

18.8K

[Update on Current Care Guideline: Headache (children)]

Mirja HämäläInen, Laimi Katri, Tanja Laukkala

    Duodecim; Laaketieteellinen Aikakauskirja
    |March 5, 2016
    PubMed

    Insights

    Most childhood recurrent headaches are treatable in primary care with paracetamol or ibuprofen. Triptans like nasal sumatriptan may be options for some children and adolescents, while propranolol is a key migraine preventative.

    Area of Science:

    • Pediatric Neurology
    • Pain Management
    • Pharmacology

    Context:

    • Recurrent headaches are common in childhood.
    • Primary healthcare settings manage most pediatric headache cases.
    • Evidence for specific headache treatments in children is evolving.

    Purpose:

    • To outline effective treatment strategies for recurrent headaches in children and adolescents.
    • To review first-line and alternative pharmacotherapies for pediatric headaches.
    • To inform primary care providers on managing pediatric headache conditions.

    Summary:

    • Primary care effectively treats most recurrent headaches in children using paracetamol and ibuprofen as first-line options.
    • Limited evidence exists for triptans in pediatric populations, but nasal sumatriptan, oral rizatriptan, and nasal zolmitriptan are potential considerations.
    • Oral almotriptan is an option for adolescents, and propranolol is recommended for migraine prophylaxis.

    Impact:

    • Empowers primary care physicians to manage pediatric headaches confidently.
    • Provides evidence-based guidance on pharmacotherapy selection for pediatric headaches.
    • Improves patient outcomes by facilitating timely and appropriate headache treatment in children.

    More Related Videos

    A Pediatric Concussion Model in Mice: Closed Head Injury with Long-Term Disorders (CHILD)07:01

    A Pediatric Concussion Model in Mice: Closed Head Injury with Long-Term Disorders (CHILD)

    Published on: February 7, 2025

    955
    Modeling Posthemorrhagic Hydrocephalus of Prematurity in Rats04:12

    Modeling Posthemorrhagic Hydrocephalus of Prematurity in Rats

    Published on: March 28, 2025

    674

    Related Concept Videos

    Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

    Pharmacokinetics in Pediatric Patients: Drug Excretion

    In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
    369
    Drug Dosing: Infants and Children01:29

    Drug Dosing: Infants and Children

    Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
    726
    Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

    Pharmacokinetics in Pediatric Patients: Drug Metabolism

    In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
    327
    Methods of reducing fever01:22

    Methods of reducing fever

    The signs and symptoms of fever include hot and dry skin, flushed face, thirst, muscle aches, anorexia, headache, tachycardia, tachypnea, and fatigue. Elevated body temperature is reduced using two methods: pharmacological and nonpharmacological. Proper identification and treatment of the root cause of a fever is of utmost importance.
    Pharmacological Methods of Reducing Fever:
    1.5K
    Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

    Pharmacokinetics in Pediatric Patients: Drug Distribution

    Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
    458
    Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

    Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

    Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
    693